USP15 and lung cancer: Regarding clinical aspects, primary LUAD patients (n = 4) with low expression of USP15 showed significant upregulation of genes (n = 10) involved in the promotion of lung cancer proliferation, migration, invasion, and metastasis, whereas tumor suppressor genes (n = 10) were downregulated.